Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, agosto 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Health Catalyst Inc
HCAT
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$1.59
N/A
In chiusura: Aug 28, 5:00 PM EST
$1.59
N/A
Post-mercato: 4:00 PM EST
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Health Catalyst Financials
Health Catalyst (HCAT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Health Catalyst Shares Tumble Overnight: What Investors Need to Know
Health Catalyst stock fell after hours after reporting Q2 results and issuing weaker third-quarter revenue guidance.
Tanya Rawat
PRO
Health Catalyst Sees FY2026 Sales $246.000M-$249.000M vs $260.780M Est
Health Catalyst (NASDAQ:HCAT) sees FY2026 sales of $246.000 million-$249.000 million vs $260.780 million analyst estimate.
Benzinga Newsdesk
PRO
Health Catalyst Sees Q3 Sales $55.000M-$56.000M vs $62.159M Est
Health Catalyst (NASDAQ:HCAT) sees Q3 sales of $55.000 million-$56.000 million vs $62.159 million analyst estimate.
Benzinga Newsdesk
PRO
Health Catalyst Q2 Adj. EPS $0.04 Beats $0.03 Estimate, Sales $70.487M Beat $69.059M Estimate
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk
PRO
Health Catalyst Sees Q2 Sales $68.000M-$70.000M vs $70.752M Est
Health Catalyst (NASDAQ:HCAT) sees Q2 sales of $68.000 million-$70.000 million vs $70.752 million analyst estimate.
Benzinga Newsdesk
PRO
Health Catalyst Q1 Adj. EPS $0.02, Inline, Sales $70.756M Beat $69.171M Estimate
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 100 percent increase over earnings of $0.01 per share from the same period last year. The
Benzinga Newsdesk
Privacy Manager